Medikinet retard now in 11 more European countries

14.09.2020

In November 2017, Medikinet retard was already granted an expansion of its registration in 11 more European countries for the treatment of ADHD in adults.

Colleagues from Germany, Denmark, the Netherlands, Norway, Iceland, Sweden and the UK then met for a strategic marketing-workshop at the beginning of 2018 at the Seilersee in Iserlohn.

Since 2011, MEDICE has been successful in the adult market and lessons learned within the German market were discussed extensively during the workshop.

Further strategies and action plans for opening up the potential in these 11 MRP-countries have now been specified and implementation has begun.